Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Cost of Revenue (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Cost of Revenue data on record, last reported at $4.2 million in Q3 2025.

  • For Q3 2025, Cost of Revenue changed 0.12% year-over-year to $4.2 million; the TTM value through Sep 2025 reached $16.6 million, down 8.74%, while the annual FY2024 figure was $16.8 million, 16.97% down from the prior year.
  • Cost of Revenue reached $4.2 million in Q3 2025 per UTMD's latest filing, down from $4.4 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $5.3 million in Q2 2022 and bottomed at -$13.3 million in Q4 2022.
  • Average Cost of Revenue over 5 years is $3.6 million, with a median of $4.6 million recorded in 2024.
  • Peak YoY movement for Cost of Revenue: skyrocketed 146.47% in 2021, then crashed 377.67% in 2022.
  • A 5-year view of Cost of Revenue shows it stood at $4.8 million in 2021, then plummeted by 377.67% to -$13.3 million in 2022, then surged by 139.27% to $5.2 million in 2023, then fell by 26.74% to $3.8 million in 2024, then rose by 9.73% to $4.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $4.2 million in Q3 2025, $4.4 million in Q2 2025, and $4.2 million in Q1 2025.